Concept and structure of MeTA

Wilbert Bannenberg Technical Director Concept and Structure of MeTA 21/7/2009

What is MeTA? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],4/12/2009 MeTA

MeTA hypothesis? ,[object Object],4/12/2009 MeTA

Transparency? ,[object Object],[object Object],[object Object],23/06/2009 MeTA

Key data collected in MeTA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],23/06/2009 MeTA ,[object Object],[object Object],[object Object],[object Object]

Contextual information collected ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],23/06/2009 MeTA

Who should disclose what? ,[object Object],[object Object],[object Object],[object Object],[object Object],23/06/2009 MeTA

What should this lead to? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],23/06/2009 MeTA

1. Responsibility for access ,[object Object],05/09/2009 3 MeTA FIP

2. Role of transparency ,[object Object],05/09/2009 3 MeTA FIP

3. Equity ,[object Object],05/09/2009 4 MeTA FIP

4. Evidence-based policy ,[object Object],05/09/2009 6 MeTA FIP 2. Affordable prices ACCESS 1. Rational selection 4. Reliable health and supply systems 3. Sustainable financing

5. Mutual accountability through mutli-stakeholder action ,[object Object],05/09/2009 7 MeTA FIP

MeTA Structure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MeTA Core Principles ,[object Object],[object Object],[object Object],[object Object],[object Object]

MeTA’s goal ,[object Object]

The MeTA Pilot Disclosure of data and scrutiny by multi - stakeholder group Development of policy options Policy change and implementation Improved information for management Improved processes . New validated data on pharmaceutical sector New validated data on pharmaceutical sector Disclosure of data and scrutiny by multi - stakeholder group Development of policy options Policy change and implementation Changes in drug prices, availability, quality and/or promotion Changes in drug prices, availability, quality and/or promotion Improved information for management Improved processes . Pilot New validated data on pharmaceutical sector Changes in drug prices, availability, quality and/or promotion ££, toolkit & technical support Policy research, shared learning Sector plans, domestic and CPs

Concept and structure of MeTA

Recommended

Recommended

More Related Content

What's hot

What's hot (19)

Similar to Concept and structure of MeTA

Similar to Concept and structure of MeTA (20)

More from MeTApresents

More from MeTApresents (20)

Concept and structure of MeTA

Editor's Notes